Bevel Secures $10M Series A Funding From General Catalyst for AI Health Companion

Why It Matters

The round underscores investor confidence in software‑only, data‑driven health solutions and could pressure hardware‑centric competitors while expanding access to proactive, personalized health management for a broader consumer base.

Deal Summary

Bevel, a New York‑based health‑tech startup, announced a $10 million Series A round led by General Catalyst to scale its AI‑driven health companion that aggregates wearable and nutrition data. The funding will support product expansion and user growth as the company targets over 100,000 daily active users.